Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
An interesting new report from the research team at Memorial Sloan-Kettering Cancer Center has explored the relationship between the patterns of occurrence of positive lymph nodes (LNs) and the topography of the cancer in the prostate and the seminal vesicles.
Filed under: Management, Treatment | Tagged: lymph nodes, pathology, pattern, topography, tumor | Leave a Comment »
It has long been understood that men with a Gleason score (GS) of 7 could be divided into two groups: those with Gleason 4 + 3 disease (in which Gleason pattern 4 was more common or “dominant”) and those with Gleason 3 + 4 disease (in which Gleason pattern 3 was dominant).
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: biochemical, Gleason, pattern, progression, risk, score | 5 Comments »
According to a new analysis of data from participants in the Health Professionals Follow-Up Study, regular physical activity is associated with an overall and a prostate cancer-specific survival benefit in men initially diagnosed with prostate cancer who show no signs of metastasis at diagnosis.
Filed under: Living with Prostate Cancer, Management | Tagged: exercise, mortality, survival | 2 Comments »
The American College of Radiology (ACR) and the American Society for Radiation Oncology (ASTRO) have jointly issued a new guidance document on the treatment of prostate cancer with permanent radioactive “seed” implants inserted through the perineum.
Filed under: Management, Treatment | Tagged: brachytherapy, guideline, Treatment | 4 Comments »
There is an interesting summary of the major, first-line management options for localized prostate cancer in today’s Washington Post. It has been prepared by the Consumer’s Union (publisher of Consumer Reports) as part of their Consumer Reports Insights series.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Consumers Union, localized, summary, Treatment | Leave a Comment »
It is widely recognized that some nutritional supplements and other dietary products seem to to have some effect on risk of prostate cancer progression. The problem is that we really don’t know why or how.
Filed under: Living with Prostate Cancer, Management | Tagged: active surveillance, COX-2, fish oil, IGF-1, low risk, lycopene, nutritional, supplement | 7 Comments »
Apparently the U.S. Food & Drug Administration (FDA) has canceled a meeting of the Oncology Drugs Advisory Committee (ODAC) that had been scheduled for February 9. The meeting was originally intended to discuss issues related to a biologics license application for ipilimumab (trade name Yervoy™).
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment, Uncategorized | Tagged: approval, FDA, ipilimumab | Leave a Comment »
According to an Associated Press story that came out this morning, Johnson & Johnson and “Boston scientists” are working together on “A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones.”
Filed under: Diagnosis, Management, Risk | Tagged: blood, circulating tumor cells, CTCs, HB-Chip | 10 Comments »
At some point in the past 3 weeks or so, the National Comprehensive Cancer Network (NCCN) Foundation has quietly issued its new NCCN Guidelines for Patients™ on prostate cancer diagnosis and management.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Diagnosis, guidelines, Management, NCCN, patient | Leave a Comment »
Awareness of brachytherapy as a treatment for localized prostate cancer was revolutionized in the U.S. in 1996 — not by a doctor but by a patient.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, Australia, Bertrand, localized | 1 Comment »
There are three major prostate cancer research studies that we expect or hope to hear results from at some time in 2011.
Filed under: Uncategorized | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site